176 related articles for article (PubMed ID: 7622202)
1. A natural mutation of the amino acid residue at position 60 destroys staphylococcal enterotoxin A murine T-cell mitogenicity.
Mahana W; al-Daccak R; Lévéillé C; Valet JP; Hébert J; Ouellette M; Mourad W
Infect Immun; 1995 Aug; 63(8):2826-32. PubMed ID: 7622202
[TBL] [Abstract][Full Text] [Related]
2. Mutations in the MHC class II binding domains of staphylococcal enterotoxin A differentially affect T cell receptor Vbeta specificity.
Newton DW; Dohlsten M; Olsson C; Segrén S; Lundin KE; Lando PA; Kalland T; Kotb M
J Immunol; 1996 Nov; 157(9):3988-94. PubMed ID: 8892632
[TBL] [Abstract][Full Text] [Related]
3. A mutation of F47 to A in staphylococcus enterotoxin A activates the T-cell receptor Vbeta repertoire in vivo.
Rosendahl A; Hansson J; Antonsson P; Sékaly RP; Kalland T; Dohlsten M
Infect Immun; 1997 Dec; 65(12):5118-24. PubMed ID: 9393804
[TBL] [Abstract][Full Text] [Related]
4. Staphylococcal enterotoxin type A internal deletion mutants: serological activity and induction of T-cell proliferation.
Harris TO; Hufnagle WO; Betley MJ
Infect Immun; 1993 May; 61(5):2059-68. PubMed ID: 8478095
[TBL] [Abstract][Full Text] [Related]
5. Mapping of staphylococcal enterotoxin A functional binding sites and presentation by monoclonal antibodies and fusion proteins.
Mahana W
Infect Immun; 1999 Apr; 67(4):1894-900. PubMed ID: 10085033
[TBL] [Abstract][Full Text] [Related]
6. Lack of complete correlation between emetic and T-cell-stimulatory activities of staphylococcal enterotoxins.
Harris TO; Grossman D; Kappler JW; Marrack P; Rich RR; Betley MJ
Infect Immun; 1993 Aug; 61(8):3175-83. PubMed ID: 8335347
[TBL] [Abstract][Full Text] [Related]
7. Identification of HLA-DR1 beta chain residues critical for binding staphylococcal enterotoxins A and E.
Karp DR; Long EO
J Exp Med; 1992 Feb; 175(2):415-24. PubMed ID: 1370684
[TBL] [Abstract][Full Text] [Related]
8. Mutation of the disulfide loop in staphylococcal enterotoxin A. Consequences for T cell recognition.
Grossman D; Van M; Mollick JA; Highlander SK; Rich RR
J Immunol; 1991 Nov; 147(10):3274-81. PubMed ID: 1834733
[TBL] [Abstract][Full Text] [Related]
9. MHC class II-independent, Vbeta-specific activation of T cells by superantigen mutants fused to anti-tumor Fab fragments: implications for use in treatment of human colon carcinoma.
Newton DW; Dohlsten M; Lando PA; Kalland T; Olsson C; Kotb M
Int J Mol Med; 1998 Jan; 1(1):157-62. PubMed ID: 9852214
[TBL] [Abstract][Full Text] [Related]
10. Identification of class II major histocompatibility complex and T cell receptor binding sites in the superantigen toxic shock syndrome toxin 1.
Hurley JM; Shimonkevitz R; Hanagan A; Enney K; Boen E; Malmstrom S; Kotzin BL; Matsumura M
J Exp Med; 1995 Jun; 181(6):2229-35. PubMed ID: 7760008
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization and role in T cell activation of staphylococcal enterotoxin A binding to the HLA-DR alpha-chain.
Thibodeau J; Dohlsten M; Cloutier I; Lavoie PM; Bjork P; Michel F; Léveillé C; Mourad W; Kalland T; Sékaly RP
J Immunol; 1997 Apr; 158(8):3698-704. PubMed ID: 9103433
[TBL] [Abstract][Full Text] [Related]
12. Residues near the amino and carboxyl termini of staphylococcal enterotoxin E independently mediate TCR V beta-specific interactions.
Lamphear JG; Mollick JA; Reda KB; Rich RR
J Immunol; 1996 Mar; 156(6):2178-85. PubMed ID: 8690907
[TBL] [Abstract][Full Text] [Related]
13. Superantigens: interaction of staphylococcal enterotoxins with MHC class II molecules.
Rich RR; Mollick JA; Cook RG
Trans Am Clin Climatol Assoc; 1990; 101():195-204; discussion 204-6. PubMed ID: 2577245
[TBL] [Abstract][Full Text] [Related]
14. Enterotoxin residues determining T-cell receptor V beta binding specificity.
Irwin MJ; Hudson KR; Fraser JD; Gascoigne NR
Nature; 1992 Oct; 359(6398):841-3. PubMed ID: 1436060
[TBL] [Abstract][Full Text] [Related]
15. An evolutionary conserved mechanism of T cell activation by microbial toxins. Evidence for different affinities of T cell receptor-toxin interaction.
Fleischer B; Gerardy-Schahn R; Metzroth B; Carrel S; Gerlach D; Köhler W
J Immunol; 1991 Jan; 146(1):11-7. PubMed ID: 1670601
[TBL] [Abstract][Full Text] [Related]
16. Staphylococcal enterotoxin D is a promiscuous superantigen offering multiple modes of interactions with the MHC class II receptors.
Al-Daccak R; Mehindate K; Damdoumi F; Etongué-Mayer P; Nilsson H; Antonsson P; Sundström M; Dohlsten M; Sékaly RP; Mourad W
J Immunol; 1998 Jan; 160(1):225-32. PubMed ID: 9551975
[TBL] [Abstract][Full Text] [Related]
17. Superantigenic staphylococcal exotoxins induce T-cell proliferation in the presence of Langerhans cells or class II-bearing keratinocytes and stimulate keratinocytes to produce T-cell-activating cytokines.
Tokura Y; Yagi J; O'Malley M; Lewis JM; Takigawa M; Edelson RL; Tigelaar RE
J Invest Dermatol; 1994 Jan; 102(1):31-8. PubMed ID: 8288908
[TBL] [Abstract][Full Text] [Related]
18. Regulation of superantigen-induced T cell activation in the absence and the presence of MHC class II.
Lando PA; Olsson C; Kalland T; Newton D; Kotb M; Dohlsten M
J Immunol; 1996 Oct; 157(7):2857-63. PubMed ID: 8816390
[TBL] [Abstract][Full Text] [Related]
19. Mutations affecting the superantigen activity of staphylococcal enterotoxin B.
Briggs C; Garcia C; Zhang L; Guan L; Gabriel JL; Rogers TJ
Immunology; 1997 Feb; 90(2):169-75. PubMed ID: 9135543
[TBL] [Abstract][Full Text] [Related]
20. Mutational analysis of the binding of staphylococcal enterotoxin D to the T cell receptor Vbeta chain and major histocompatibility complex class II.
Li Y; Zhu X; Huang Y; Xiong H
Immunol Lett; 2006 May; 105(1):55-60. PubMed ID: 16481046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
